Dr. Reddy’s Weak Earnings: Margins Slip to 23.3%, U.S. Pain Deepens | Share Market | Business@9　 #ETNOW

Dr. Reddy’s Laboratories has reported a weak set of Q2 FY26 earnings, with profits and margins missing street expectations. North American sales fell 13% due to price erosion and lower Lenalidomide volumes. CEO Erez Israeli explains the key reasons behind the fall, outlook for India’s double-digit growth, and upcoming R&D milestones. Tune in for insights on what lies ahead for one of India’s biggest pharma names.

#drreddys #earnings #pharma #stocks #etnow #markets #businessnews

control your money with economic times now.

YouTube Channel – https://www.youtube.com/@ETNow

Subscribe To ET Now For Latest Updates On Stocks Market News , Business News, Company News, IPO & More | https://bit.ly/SubscribeToETNow

Subscribe Now To Our Network Channels :-
ET Now Swadesh: https://www.youtube.com/etnowswadesh
Times Now: http://goo.gl/U9ibPb

Social Media Links :-
Twitter – http://goo.gl/hA0vDt
Facebook – http://goo.gl/5Lr4mC

Website – https://ift.tt/wYvVfp3